Q3 2019 Holdings
Filed 2019-11-14 | 19 holdings | $2.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $1.4M | 479,902 | 57.8% |
| Arcosa Inc(ACA) | COM | 039653100 | $955.0K | 27,923 | 40.2% |
| Berkshire Hathaway Inc del(BRK/A) | CL A | 084670108 | $31.2K | 100 | 1.3% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $2.4K | 67,753 | 0.1% |
| Synthorx Inc | COM | 87167A103 | $2.4K | 145,150 | 0.1% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $1.6K | 78,212 | 0.1% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $1.6K | 71,856 | 0.1% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $1.4K | 59,690 | 0.1% |
| Meiragtx Holdings PLC(MGTX) | COM | G59665102 | $1.3K | 81,176 | 0.1% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $1.3K | 108,692 | 0.1% |
| Zogenix Inc | COM NEW | 98978L204 | $997 | 24,890 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $925 | 49,974 | 0.0% |
| Retrophin Inc | COM | 761299106 | $895 | 77,180 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $762 | 146,475 | 0.0% |
| Genomic Health Inc(GHDX) | COM | 37244C101 | $645 | 9,506 | 0.0% |
| Summit Midstream Partners LP | COM UNIT LTD | 866142102 | $342 | 70,456 | 0.0% |
| Cocrystal Pharma Inc | COM PAR | 19188J300 | $312 | 152,916 | 0.0% |
| Spdr S&P 500 ETF TR(SPY) | TR UNIT | 78462F103 | $280 | 942 | 0.0% |
| Inflarx NV(IFRX) | COM | N44821101 | $91 | 36,818 | 0.0% |